EP272: Heart Failure and Lipid Conference Part 2

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Podcast Episode Summary Introduction Dr. Warrick Bishop, a cardiologist, author, and CEO of the Healthy Heart Network, hosts this episode as part two of a medical conference covering heart disease prevention and management. The episode focuses on emerging cardiovascular research topics presented by leading experts, including lipoprotein A, fatty liver disease, adipose tissue, and advances in heart failure assessment. Dr. Bishop aims to translate complex cardiology concepts into actionable health information for his audience, emphasizing that many heart attacks could be prevented with proper knowledge. Key Takeaways: Lipoprotein A (Lp(a)) is an important but underrecognized lipid particle with a distinctive "sticky tail" structure that can accumulate in artery walls, contributing to the residual cardiovascular risk that remains even after cholesterol-lowering therapy. Lipoprotein A is the most common hereditary marker for premature coronary artery disease and also increases the risk of aortic stenosis, making screening and management guidelines increasingly important. Causal artificial intelligence and Mendelian randomization are being used to refine cardiovascular risk assessment by incorporating randomized controlled trial data, potentially transforming clinical practice within months to years. Non-alcoholic fatty liver disease is becoming a major cause of cirrhosis and typically coexists with significant coronary artery disease risk factors; weight reduction is the key intervention regardless of method. Visceral fat (surrounding organs) is more metabolically harmful than subcutaneous fat, as it drives inflammation and impacts microvessels; this distinction is demonstrated by the different health outcomes of active versus sedentary sumo wrestlers. Strain imaging, which evaluates how heart muscle behaves under load during both contraction and relaxation, represents a more sophisticated assessment method than traditional ejection fraction measurements alone. Genetic markers are increasingly important for identifying individuals predisposed to heart failure, whether occurring naturally or triggered by external factors such as chemotherapy, alcohol, or infections. Current Australian position papers and cardiovascular risk assessment tools are being updated to incorporate lipoprotein A testing and management recommendations based on emerging evidence.